Arrhythmic complications of tyrosine kinase inhibitors

Michael G Fradley; Javier Pinilla-Ibarz

doi:10.2217/FCA.15.42

Arrhythmic complications of tyrosine kinase inhibitors

Future Cardiol. 2015 Jul;11(4):395-9. doi: 10.2217/FCA.15.42. Epub 2015 Aug 4.

Authors

Michael G Fradley¹, Javier Pinilla-Ibarz²

Affiliations

¹ Division of Cardiovascular Medicine, University of South Florida, Morsani College of Medicine, 2 Tampa General Circle, Tampa, FL 33606, USA.
² Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

PMID: 26238220
DOI: 10.2217/FCA.15.42

No abstract available

Keywords: QT prolongation; Torsades de Pointes; arrhythmia; atrial fibrillation; cancer treatment; cardiotoxicity; chemotherapy; tyrosine kinase inhibitors.

MeSH terms

Arrhythmias, Cardiac / chemically induced*
Arrhythmias, Cardiac / diagnosis
Arrhythmias, Cardiac / therapy
Humans
Protein Kinase Inhibitors / adverse effects*
Protein-Tyrosine Kinases / antagonists & inhibitors*

Substances

Protein Kinase Inhibitors
Protein-Tyrosine Kinases